You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華大基因(300676.SZ)一季度實現淨利潤1.40億元 同比增長42.59%
格隆匯 04-25 01:16

格隆匯4月25日丨華大基因(300676.SZ)發佈2020年第一季度報告,報告期內,公司實現營業總收入7.91億元,同比增長35.78%;歸屬於上市公司股東的淨利潤1.40億元,同比增長42.59%;基本每股收益0.35元。

報告期內,公司圍繞總體發展戰略,根據董事會制定的2020年度經營計劃,有序地推進各項工作。報告期內,新冠病毒肺炎疫情在全球範圍內爆發,公司加快感染防控業務的研發佈局,快速研製了基於RT-PCR技術的新冠病毒檢測試劑盒,該產品首批通過國家藥品監督管理局應急審批程序獲准上市,並已陸續獲得歐盟CEIVD資質、美國FDAEUA資質、日本PMDA資質和澳大利亞TGA資質。在交付能力的打造上,加強精準檢測能力建設和擴展,在檢測設備、檢測方法和檢測通量提升上取得快速進展,從資質申報到生產交付全力保障疫情防控期間的檢測需求。

在內部管理方面,不斷拓寬各主營業務板塊的服務領域和產品線;加強對渠道的建設和管理;全面推進預算管理,有效控制運營成本;持續加強內部控制和規範運作,全面提升企業的經營管理效率,力爭完成董事會制定的各項經營計劃,實現公司的穩定持續發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account